Table 2 Sensitivity analysis of the prevalence of dual contraceptive utilization among HIV positive women in Ethiopia 2020

Abay et al. (2020) [13]

25.99

20.82–31.16

Reta et al. (2019) [14]

26.86

21.79–31.95

Kebede et al. (2015) [15]

26.11

20.92–31.30

Egzeabher et al. (2015) [16]

26.54

21.34–31.74

Tewabe et al. (2018)

26.15

20.95–31.35

Asfaw et al. (2014) [17]

26.59

21.40–31.78

Demissie et al. (2015) [18]

25.81

20.69–30.93

Sufa et al. (2013) [19]

26.35

21.13–31.56

Polis et al. (2014) [20]

26.65

21.47–31.82

Dereje (2019) [21]

24.28

20.37–28.18

Feyissa et al. (2020) [22]

26.65

21.47–31.82

Tesfaye et al. (2014) [23]

25.82

20.69–30.94

Gebrehiwot et al. (2017) [24]

26.72

21.57–31.87

Kalayu (2019) [25]

25.08

20.31–29.85

Melaku et al. (2014) [26]

26.81

21.72–31.91

Berhane et al. (2013) [27]

26.39

21.17–31.60

Assefa et al. (2014) [28]

25.32

20.40–30.23

Markos et al. (2019) [29]

26.02

20.84–31.19

Meseret et al. (2015) [30]

26.49

21.28–31.70